CC10 administration to premature infants: in search of the "silver bullet" to prevent lung inflammation.
Welty
Stephen E
SE
Columbus Children's Research Institute, 700 Children's Drive, Columbus, OH 43205, USA. weltys@pediatrics.ohio-state.edu
D001997:Bronchopulmonary Dysplasia / Q000473:pathology; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D007249:Inflammation; D008168:Lung / Q000276:immunology / Q000473:pathology; D008171:Lung Diseases / Q000188:drug therapy*; D009504:Neutrophils / Q000378:metabolism; D018384:Oxidative Stress; D011014:Pneumonia / Q000188:drug therapy* / Q000517:prevention & control*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*; D013997:Time Factors; D014598:Uteroglobin / Q000008:administration & dosage*
C556389:SCGB1A1 protein, human; D014598:Uteroglobin